Overview

Intravenous (IV) Pantoprazole in Erosive Esophagitis

Status:
Completed

Trial end date:
2007-03-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to examine whether pantoprazole (Protonix) given through continuous intravenous infusion for 72 hours is superior to Protonix given through once a day IV injection in the treatment of erosive esophagitis.

Phase:

Phase 4

Details

Lead Sponsor:

Emory University

Collaborator:

Wyeth is now a wholly owned subsidiary of Pfizer

Treatments:

Pantoprazole